CDK2 and breast carcinoma: Hyperactivation of CDK2 is correlated with cyclins A and E overexpression and/or amplification in human cancers, particularly lung, thyroid, ovarian, endometrial, and breast carcinoma, osteosarcoma, and melanoma [33].